Encapsulation of cucurbitacin B into lipid polymer hybrid nanocarriers induced apoptosis of MDAMB231 cells through PARP cleavage
- 1 August 2020
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 586, 119565
Abstract
No abstract availableKeywords
Funding Information
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
This publication has 53 references indexed in Scilit:
- Application of spray granulation for conversion of mixed phospholipid-bile salt micelles to dry powder form: influence of drug hydrophobicity on nanoparticle reagglomerationInternational Journal of Nanomedicine, 2014
- Surface Engineering of Liposomes for Stealth BehaviorPharmaceutics, 2013
- Cellular Mechanisms Controlling Caspase Activation and FunctionCold Spring Harbor Perspectives in Biology, 2013
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery CarrierPolymers, 2011
- Polymeric Nanoparticles with Precise Ratiometric Control over Drug Loading for Combination TherapyMolecular Pharmaceutics, 2011
- Advances in Novel Drug Delivery Strategies for Breast Cancer TherapyArtificial Cells, Blood Substitutes, and Biotechnology, 2010
- Half-Antibody Functionalized Lipid−Polymer Hybrid Nanoparticles for Targeted Drug Delivery to Carcinoembryonic Antigen Presenting Pancreatic Cancer CellsMolecular Pharmaceutics, 2010
- Galactosylated solid lipid nanoparticles with cucurbitacin B improves the liver targetabilityDrug Delivery, 2010
- NF-κB and cancer — identifying targets and mechanismsCurrent Opinion in Genetics & Development, 2008
- Inhibition of Nitric Oxide Generation by 23,24-Dihydrocucurbitacin D in Mouse Peritoneal MacrophagesThe Journal of Pharmacology and Experimental Therapeutics, 2004